Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2011 5
2012 9
2013 12
2014 14
2015 11
2016 16
2017 11
2018 7
2019 15
2020 11
2021 14
2022 13
2023 13
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for al badar
Search for Ali Bazdar instead (2 results)
Lip repositioning.
Gaddale R, Desai SR, Mudda JA, Karthikeyan I. Gaddale R, et al. J Indian Soc Periodontol. 2014 Mar;18(2):254-8. doi: 10.4103/0972-124X.131349. J Indian Soc Periodontol. 2014. PMID: 24872640 Free PMC article.
Occlusion calculator.
Bansal A, Hiremath A, Aluckal E. Bansal A, et al. J Clin Diagn Res. 2015 Jan;9(1):ZG01-3. doi: 10.7860/JCDR/2015/9438.5460. Epub 2015 Jan 1. J Clin Diagn Res. 2015. PMID: 25738101 Free PMC article.
Recent advances in understanding and treating immunoglobulin light chain amyloidosis.
Badar T, D'Souza A, Hari P. Badar T, et al. F1000Res. 2018 Aug 29;7:F1000 Faculty Rev-1348. doi: 10.12688/f1000research.15353.1. eCollection 2018. F1000Res. 2018. PMID: 30228867 Free PMC article. Review.
Early referral to a specialized center with expertise in management of AL amyloidosis is always recommended. The availability of sensitive biomarkers and novel therapies is reforming our approach to how we manage AL amyloidosis. Treatment for patients with AL …
Early referral to a specialized center with expertise in management of AL amyloidosis is always recommended. The availability of sens …
Effectiveness of Hall Technique for Primary Carious Molars: A Systematic Review and Meta-analysis.
Badar SB, Tabassum S, Khan FR, Ghafoor R. Badar SB, et al. Int J Clin Pediatr Dent. 2019 Sep-Oct;12(5):445-452. doi: 10.5005/jp-journals-10005-1666. Int J Clin Pediatr Dent. 2019. PMID: 32440052 Free PMC article. Review.
CONCLUSION: HT appeared demonstrated higher success and significantly outperformed the conventional restorations. HOW TO CITE THIS ARTICLE: Badar SB, Tabassum S, Khan FR, et al. Effectiveness of Hall Technique for Primary Carious Molars: A Systematic Review and Meta …
CONCLUSION: HT appeared demonstrated higher success and significantly outperformed the conventional restorations. HOW TO CITE THIS ARTICLE: …
Parotid angiofibroma.
Hallur NH, Zainab H, Shah A, Siddiqua A. Hallur NH, et al. J Oral Maxillofac Pathol. 2014 May;18(2):295-8. doi: 10.4103/0973-029X.140798. J Oral Maxillofac Pathol. 2014. PMID: 25328316 Free PMC article.
Elongated Pterygoid Hamulus: A case Report.
Shah A, Guduba V, Tejaswini K, Kothari C. Shah A, et al. Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3830-3833. doi: 10.1007/s12070-023-03853-8. Epub 2023 May 17. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37974797
Magical NiTi expander.
Katti CG, Katti G, Kallur R, Ghali SR. Katti CG, et al. BMJ Case Rep. 2013 Jul 17;2013:bcr2013009140. doi: 10.1136/bcr-2013-009140. BMJ Case Rep. 2013. PMID: 23867876 Free PMC article.
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
Al-Kali A, Nanaa A, Viswanatha D, He R, Nguyen P, Jevremovic D, Foran JM, Yi CA, Greipp PT, Gangat N, Patnaik M, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Badar T, Alkhateeb HB. Al-Kali A, et al. Blood Cancer J. 2023 Apr 10;13(1):49. doi: 10.1038/s41408-023-00818-6. Blood Cancer J. 2023. PMID: 37032414 Free PMC article. No abstract available.
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free article.
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.
Mensah GA, Fuster V, Murray CJL, Roth GA; Global Burden of Cardiovascular Diseases and Risks Collaborators. Mensah GA, et al. J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007. J Am Coll Cardiol. 2023. PMID: 38092509 No abstract available.
144 results